Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes
暂无分享,去创建一个
E. Antman | M. Sabatine | E. Braunwald | C. Cannon | D. Morrow | S. Murphy | J. D. de Lemos | C. McCabe | C. Gibson | David A. Morrow | Christopher P. Cannon | C. Mccabe | C. Gibson | Marc S. Sabatine | M. Sabatine | C. Cannon
[1] D. Memmos,et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] S. Störk,et al. The effect of 17β-estradiol on MCP-1 serum levels in postmenopausal women , 2002 .
[3] S. Adamopoulos,et al. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[4] Y. Kaneda,et al. Local Overexpression of Monocyte Chemoattractant Protein‐1 at Vessel Wall Induces Infiltration of Macrophages and Formation of Atherosclerotic Lesion: Synergism With Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[5] W. Daniel,et al. Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate Hypercholesterolemia , 2001, Circulation.
[6] L. Badimón,et al. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. , 2001, Atherosclerosis.
[7] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.
[8] C. Stefanadis,et al. Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty. , 2001, International journal of cardiology.
[9] A. Aljada,et al. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. , 2001, The Journal of clinical endocrinology and metabolism.
[10] M. Reale,et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[11] P. Théroux,et al. Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes. , 2000, Journal of the American College of Cardiology.
[12] A. Skene,et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. , 2000, Circulation.
[13] A. Mantovani,et al. Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins , 2000, Laboratory Investigation.
[14] A. Matsumori,et al. Roles and Relationship of Macrophages and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Ischemic and Reperfused Rat Heart , 2000, Laboratory Investigation.
[15] J. Parissis,et al. Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. , 2000, The American journal of cardiology.
[16] P. Groot,et al. Chemokines and atherosclerosis. , 1999, Atherosclerosis.
[17] Y. L. Chen,et al. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits. , 1999, Circulation.
[18] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[19] Y. Ouchi,et al. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[20] N. Maeda,et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.
[21] J. Kelley,et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[22] O. Quehenberger,et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[23] H. Adelsberger,et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. , 1998, Circulation.
[24] K. Kugiyama,et al. Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes. , 1998, Japanese circulation journal.
[25] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[26] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[27] J. Kjekshus,et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. , 1998, Circulation.
[28] J. Kuratsu,et al. Monocyte chemoattractant protein‐1 enhances expression of intercellular adhesion molecule‐1 following ischemia‐reperfusion of the liver in rats , 1998, Hepatology.
[29] B. Rollins,et al. Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells* , 1997, The Journal of Biological Chemistry.
[30] C. Mackay,et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. , 1997, Circulation.
[31] C. Mackay,et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. , 1997, Circulation.
[32] A. J. Valente,et al. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. , 1995, Circulation research.
[33] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[34] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.